ASH 2020: Pooled analysis examined the incidence of cardiovascular events in patients with CLL treated with acalabrutinib.
Home / Resource Library / Pooled Analysis of Cardiovascular Events from Clinical Trials Evaluating Acalabrutinib Monotherapy in Patients with Chronic Lymphocytic Leukemia (CLL)